bupivacaine has been researched along with Cytomegalic Inclusion Disease in 2 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
James, CM | 1 |
Bartlett, EJ | 1 |
Mansfield, JP | 1 |
Cull, VS | 1 |
Endrész, V | 1 |
Burián, K | 1 |
Berencsi, K | 1 |
Gyulai, Z | 1 |
Kari, L | 1 |
Horton, H | 1 |
Virok, D | 1 |
Méric, C | 1 |
Plotkin, SA | 1 |
Gönczöl, E | 1 |
2 other studies available for bupivacaine and Cytomegalic Inclusion Disease
Article | Year |
---|---|
Interferon subtype gene therapy for regulating cytomegalovirus disease.
Topics: Anesthetics, Local; Animals; Bupivacaine; Cytomegalovirus Infections; Gene Transfer Techniques; Gene | 2005 |
Optimization of DNA immunization against human cytomegalovirus.
Topics: Animals; Antibodies, Viral; Antigens, Viral; Bupivacaine; Cytomegalovirus; Cytomegalovirus Infection | 2001 |